401 related articles for article (PubMed ID: 16310567)
41. Membranous nephropathy in the older adult: epidemiology, diagnosis and management.
Deegens JK; Wetzels JF
Drugs Aging; 2007; 24(9):717-32. PubMed ID: 17727303
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
[TBL] [Abstract][Full Text] [Related]
43. ACTH and azathioprine: antiproteinuric and lipid-lowering effect in the course of idiopathic membranous glomerulonephritis.
Gigante A; Rosato E; Liberatori M; Gasperini ML; Giannakakis K; Barbano B; Cianci R; Salsano F; Amoroso A
J Biol Regul Homeost Agents; 2012; 26(1):135-8. PubMed ID: 22475105
[TBL] [Abstract][Full Text] [Related]
44. Early prediction of treatment outcome in idiopathic membranous nephropathy.
O'Callaghan CA; Cameron JS; Sacks SH
QJM; 1995 Dec; 88(12):889-94. PubMed ID: 8593548
[TBL] [Abstract][Full Text] [Related]
45. Rituximab for idiopathic membranous nephropathy: who can benefit?
Ruggenenti P; Chiurchiu C; Abbate M; Perna A; Cravedi P; Bontempelli M; Remuzzi G
Clin J Am Soc Nephrol; 2006 Jul; 1(4):738-48. PubMed ID: 17699281
[TBL] [Abstract][Full Text] [Related]
46. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.
Gansevoort RT; Heeg JE; Vriesendorp R; de Zeeuw D; de Jong PE
Nephrol Dial Transplant; 1992; 7 Suppl 1():91-6. PubMed ID: 1337189
[TBL] [Abstract][Full Text] [Related]
47. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
Westphal S; Hansson S; Mjörnstedt L; Mölne J; Swerkersson S; Friman S
Transplant Proc; 2006 Oct; 38(8):2659-60. PubMed ID: 17098031
[TBL] [Abstract][Full Text] [Related]
48. [Membranous nephropathy].
Passos EM; Legallicier B; Godin M
Rev Prat; 2003 Nov; 53(18):2033-8. PubMed ID: 15008218
[TBL] [Abstract][Full Text] [Related]
49. Overview of current and alternative therapies for idiopathic membranous nephropathy.
Tran TH; J Hughes G; Greenfeld C; Pham JT
Pharmacotherapy; 2015 Apr; 35(4):396-411. PubMed ID: 25884528
[TBL] [Abstract][Full Text] [Related]
50. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
Polenakovik MH; Grcevska L
Am J Kidney Dis; 1999 Nov; 34(5):911-7. PubMed ID: 10561149
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
52. IgA nephropathy and Henoch-Schönlein purpura nephritis.
Sanders JT; Wyatt RJ
Curr Opin Pediatr; 2008 Apr; 20(2):163-70. PubMed ID: 18332712
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.
van den Brand JA; Hofstra JM; Wetzels JF
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1242-8. PubMed ID: 22595828
[TBL] [Abstract][Full Text] [Related]
54. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
55. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
56. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
Frigui M; Hmida MB; Jallouli M; Kechaou M; Frikha F; Bahloul Z
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):320-2. PubMed ID: 20228521
[TBL] [Abstract][Full Text] [Related]
57. Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy.
Reichert LJ; Koene RA; Wetzels JF
J Am Soc Nephrol; 1995 Dec; 6(6):1666-9. PubMed ID: 8749696
[TBL] [Abstract][Full Text] [Related]
58. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
Polenakovic M; Grcevska L; Dzikova S
Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
[TBL] [Abstract][Full Text] [Related]
59. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
Murphy BF; Fairley KF; Kincaid-Smith PS
Clin Nephrol; 1988 Oct; 30(4):175-81. PubMed ID: 3214963
[TBL] [Abstract][Full Text] [Related]
60. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
